- Autor(en)
- Russell, Nigel H
- Artikel
- Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With NPM1 and FLT3 Mutations
- Titel
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
- Verlag
- Published for the American Society of Clinical Oncology by Lippincott Williams & Wilkins with the assistance of Stanford University's HighWire Press
- Ort
- Baltimore, MD :
- Erscheinungsjahr
- 1983
Leider kein Volltext verfügbar.
Weitere Recherchemöglichkeiten